Ethel Cesarman - Publications

Affiliations: 
Weill Cornell Medical College, New York, NY, United States 
Area:
Cell Biology, Virology Biology

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cesarman E, Chadburn A, Rubinstein PG. KSHV/HHV8-mediated hematologic diseases. Blood. PMID 34479367 DOI: 10.1182/blood.2020005470  1
2021 Guasparri I, Keller SA, Cesarman E. Retraction: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells. The Journal of Experimental Medicine. 218. PMID 33599700 DOI: 10.1084/jem.2003146702062021r  1
2020 Willcockson MA, Healton SE, Weiss CN, Bartholdy BA, Botbol Y, Mishra LN, Sidhwani DS, Wilson TJ, Pinto HB, Maron MI, Skalina KA, Toro LN, Zhao J, Lee CH, Hou H, ... ... Cesarman E, et al. H1 histones control the epigenetic landscape by local chromatin compaction. Nature. PMID 33299182 DOI: 10.1038/s41586-020-3032-z  0.01
2020 Yusufova N, Kloetgen A, Teater M, Osunsade A, Camarillo JM, Chin CR, Doane AS, Venters BJ, Portillo-Ledesma S, Conway J, Phillip JM, Elemento O, Scott DW, Béguelin W, Licht JD, ... ... Cesarman E, et al. Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature. PMID 33299181 DOI: 10.1038/s41586-020-3017-y  1
2020 Scholze H, Stephenson RE, Reynolds R, Shah S, Puri R, Butler SD, Trujillo-Alonso V, Teater MR, van Besien H, Gibbs-Curtis D, Ueno H, Parvin S, Letai A, Mathew S, Singh A, ... Cesarman E, et al. Combined EZH2 and Bcl-2 inhibitors as precision therapy for genetically defined DLBCL subtypes. Blood Advances. 4: 5226-5231. PMID 33104794 DOI: 10.1182/bloodadvances.2020002580  1
2020 Medina MV, D Agostino A, Ma Q, Eroles P, Cavallin L, Chiozzini C, Sapochnik D, Cymeryng C, Hyjek E, Cesarman E, Naipauer J, Mesri EA, Coso OA. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Plos Pathogens. 16: e1009006. PMID 33057440 DOI: 10.1371/journal.ppat.1009006  1
2020 Lin LL, Lakomy DS, Chiao EY, Strother RM, Wirth M, Cesarman E, Borok M, Busakhala N, Chibwesha CJ, Chinula L, Ndlovu N, Orem J, Phipps W, Sewram V, Vogt SL, et al. Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers. Jco Global Oncology. 6: 1134-1146. PMID 32697667 DOI: 10.1200/GO.20.00153  1
2020 Strother RM, Gopal S, Wirth M, Chadburn A, Noy A, Cesarman E, Lee JY, Remick SC, Busakhala N, Kaimila B, Mberi E, Ndlovu N, Omoding A, Krown SE. Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. Jco Global Oncology. 6: 1034-1040. PMID 32634068 DOI: 10.1200/GO.20.00152  1
2020 Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand C, Cesarman E, Aboulafia DM, Baiocchi RA, Ratner L, Kaplan LD, Capoferri AA, et al. Impact of Myc in HIV-associated Non-Hodgkin Lymphomas Treated with EPOCH, and Outcomes with Vorinostat (AMC075 Trial). Blood. PMID 32430507 DOI: 10.1182/Blood.2019003959  1
2020 Guo R, Zhang Y, Teng M, Jiang C, Schineller M, Zhao B, Doench JG, O'Reilly RJ, Cesarman E, Giulino-Roth L, Gewurz BE. DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nature Microbiology. PMID 32424339 DOI: 10.1038/S41564-020-0724-Y  1
2020 Sadek J, Wuo MG, Rooklin D, Hauenstein A, Hong SH, Gautam A, Wu H, Zhang Y, Cesarman E, Arora PS. Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics. Nature Communications. 11: 1786. PMID 32286300 DOI: 10.1038/S41467-020-15576-3  1
2020 Dalton T, Doubrovina E, Pankov D, Reynolds RC, Scholze H, Selvakumar A, Vizconde T, Savalia B, Dyomin V, Weigel C, Oakes CC, Alonso A, Elemento O, Pan H, Phillip JM, ... ... Cesarman E, et al. Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to viral directed immunotherapy. Blood. PMID 32157281 DOI: 10.1182/Blood.2019004126  1
2020 Sparano JA, Lee JY, Kaplan LD, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV- associated, B-cell non-Hodgkin's lymphoma. Haematologica. PMID 32107337 DOI: 10.3324/Haematol.2019.243386  1
2020 Ruder B, Günther C, Stürzl M, Neurath MF, Cesarman E, Ballon G, Becker C. Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo. Plos One. 15: e0228441. PMID 31999759 DOI: 10.1371/Journal.Pone.0228441  1
2019 Yusufova N, Teater MR, Soshnev A, Kloetgen A, Osunsade A, Conway J, Doane A, Skoultchi A, Tsirigos A, David Y, Allis CD, Cesarman E, Melnick A. Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome. Blood. 134: 23. PMID 31723979 DOI: 10.1182/Blood-2019-127774  0.01
2019 Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nature Reviews. Disease Primers. 5: 9. PMID 30705286 DOI: 10.1038/s41572-019-0060-9  1
2018 Snodgrass R, Gardner A, Semeere A, Kopparthy V, Duru J, Maurer T, Martin J, Cesarman E, Erickson D. A portable device for nucleic acid quantification powered by sunlight, a flame or electricity. Nature Biomedical Engineering. 2: 657-665. PMID 30906647 DOI: 10.1038/S41551-018-0286-Y  1
2018 Reid EG, Looney D, Maldarelli F, Noy A, Henry D, Aboulafia D, Ramos JC, Sparano J, Ambinder RF, Lee J, Cesarman E, Yahyaei S, Mitsuyasu R, Wachsman W. Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Advances. 2: 3618-3626. PMID 30573564 DOI: 10.1182/Bloodadvances.2018022095  1
2018 Ruder B, Murtadak V, Stürzl M, Wirtz S, Distler U, Tenzer S, Mahapatro M, Greten FR, Hu Y, Neurath MF, Cesarman E, Ballon G, Günther C, Becker C. Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells. Mucosal Immunology. PMID 30104627 DOI: 10.1038/S41385-018-0068-6  1
2018 Ayers LW, Barbachano-Guerrero A, McAllister SC, Ritchie JA, Asiago-Reddy E, Bartlett LC, Cesarman E, Wang D, Rochford R, Martin JN, King CA. Mast cell activation and KSHV infection in Kaposi sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30084838 DOI: 10.1158/1078-0432.Ccr-18-0873  0.01
2018 Totonchy J, Osborn JM, Chadburn A, Nabiee R, Argueta L, Mikita G, Cesarman E. KSHV induces immunoglobulin rearrangements in mature B lymphocytes. Plos Pathogens. 14: e1006967. PMID 29659614 DOI: 10.1371/Journal.Ppat.1006967  1
2018 Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, Henry D, Ratner L, Aboulafia D, Lee JY, Ambinder RF, Mitsuyasu R, Noy A. Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical Lymphoma, Myeloma & Leukemia. PMID 29426719 DOI: 10.1016/J.Clml.2018.01.004  1
2018 Ramos JC, Sparano JA, Moore PC, Cesarman E, Reid EG, Rubinstein PG, Harrington RD, Baiocchi RA, Aboulafia DM, Ratner L, Lawrence K, Durand C, Ambinder R, Lee JY, Mitsuyasu RT, et al. AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL. Journal of Clinical Oncology. 36: 7573-7573. DOI: 10.1200/Jco.2018.36.15_Suppl.7573  1
2017 Schulz TF, Cesarman E. Editorial overview: Viruses and cancer: How tumor viruses affect the cellular genome. Current Opinion in Virology. 26: vi-vii. PMID 29107266 DOI: 10.1016/J.Coviro.2017.10.005  1
2017 McHugh D, Caduff N, Barros MHM, Rämer PC, Raykova A, Murer A, Landtwing V, Quast I, Styles CT, Spohn M, Fowotade A, Delecluse HJ, Papoudou-Bai A, Lee YM, Kim JM, ... ... Cesarman E, et al. Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell Host & Microbe. 22: 61-73.e7. PMID 28704654 DOI: 10.1016/J.Chom.2017.06.009  1
2017 Reichel JB, McCormick J, Fromm JR, Elemento O, Cesarman E, Roshal M. Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma. Journal of Visualized Experiments : Jove. PMID 28654052 DOI: 10.3791/54399  1
2017 Giulino-Roth L, Van Besien HJ, Dalton T, Totonchy JE, Rodina A, Taldone T, Bolaender A, Erdjument-Bromage H, Sadek J, Chadburn A, Barth MJ, Dela Cruz FS, Rainey A, Kung AL, Chiosis G, ... Cesarman E, et al. Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma. Molecular Cancer Therapeutics. PMID 28619753 DOI: 10.1158/1535-7163.Mct-16-0848  1
2017 Nayar U, Sadek J, Reichel J, Hernandez-Hopkins D, Akar G, Barelli PJ, Sahai MA, Zhou H, Totonchy J, Jayabalan D, Niesvizky R, Guasparri I, Hassane D, Liu Y, Sei S, ... ... Cesarman E, et al. Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies. The Journal of Clinical Investigation. PMID 28504647 DOI: 10.1172/Jci83936  1
2017 Müller-Coan BG, Cesarman E, Oliveira DED. Abstract 5756: Effects of Epstein-Barr virus latent membrane protein 1 (LMP1) on cell invasiveness and expression of endogenous microRNAs in human cellsin vitro Cancer Research. 77: 5756-5756. DOI: 10.1158/1538-7445.Am2017-5756  0.01
2017 Sadek J, Nayar U, Reichel J, Totonchy J, Sei S, Shoemaker R, Warren D, Elemento O, Kaye K, Cesarman E. Abstract 5110: A novel nucleoside analog therapeutically active against plasma cell malignancies and other ADK-expressing cancers including colon and pancreatic adenocarcinomas Cancer Research. 77: 5110-5110. DOI: 10.1158/1538-7445.Am2017-5110  1
2016 Rodina A, Wang T, Yan P, Gomes ED, Dunphy MP, Pillarsetty N, Koren J, Gerecitano JF, Taldone T, Zong H, Caldas-Lopes E, Alpaugh M, Corben A, Riolo M, Beattie B, ... ... Cesarman E, et al. The epichaperome is an integrated chaperome network that facilitates tumour survival. Nature. PMID 27706135 DOI: 10.1038/Nature19807  1
2016 Totonchy J, Cesarman E. Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy? Current Opinion in Virology. 20: 71-77. PMID 27665065 DOI: 10.1016/J.Coviro.2016.09.001  1
2016 Snodgrass R, Gardner A, Jiang L, Fu C, Cesarman E, Erickson D. KS-Detect - Validation of Solar Thermal PCR for the Diagnosis of Kaposi's Sarcoma Using Pseudo-Biopsy Samples. Plos One. 11: e0147636. PMID 26799834 DOI: 10.1371/Journal.Pone.0147636  1
2015 Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Current Opinion in Virology. 14: 116-28. PMID 26431609 DOI: 10.1016/J.Coviro.2015.08.016  1
2015 Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L. AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 126: 160-6. PMID 25957391 DOI: 10.1182/Blood-2015-01-623900  1
2015 Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E. The tumor virus landscape of AIDS-related lymphomas. Blood. 125: e14-22. PMID 25827832 DOI: 10.1182/Blood-2014-11-599951  1
2015 Ballon G, Akar G, Cesarman E. Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo. Plos Pathogens. 11: e1004581. PMID 25607954 DOI: 10.1371/Journal.Ppat.1004581  1
2015 Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, ... Cesarman E, et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 125: 1061-72. PMID 25488972 DOI: 10.1182/Blood-2014-11-610436  1
2015 Ma SD, Xu X, Plowshay J, Ranheim EA, Burlingham WJ, Jensen JL, Asimakopoulos F, Tang W, Gulley ML, Cesarman E, Gumperz JE, Kenney SC. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. The Journal of Clinical Investigation. 125: 304-15. PMID 25485679 DOI: 10.1172/Jci76357  1
2015 Ballon G, Akar G, Cesarman E. Systemic Expression of Kaposi Sarcoma Herpesvirus (KSHV) Vflip in Endothelial Cells Leads to a Profound Proinflammatory Phenotype and Myeloid Lineage Remodeling In Vivo Plos Pathogens. 11: 1-20. DOI: 10.1371/journal.ppat.1004581  1
2015 Reichel J, Brody J, Elemento O, Rabadan R, Cesarman E. Abstract 4750: Transcriptome sequencing of the Reed-Sternberg cells of classical Hodgkin lymphoma Cancer Research. 75: 4750-4750. DOI: 10.1158/1538-7445.Am2015-4750  1
2015 Nayar U, Reichel J, Sadek J, Hernandez-Hopkins D, Akar G, Zhou H, Sahai MA, Barelli P, Guasparri I, Totonchy J, Hassane D, Sei S, Shoemaker RH, Warren JD, Elemento O, ... ... Cesarman E, et al. Abstract 4496: Genomics-based resistome analysis revealed endogenous adenosine kinase levels as a chief determinant of specificity for a novel nucleoside analog lymphoma inhibitor Cancer Research. 75: 4496-4496. DOI: 10.1158/1538-7445.Am2015-4496  1
2015 Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: Mechanisms of oncogenesis Current Opinion in Virology. 14: 116-128. DOI: 10.1016/j.coviro.2015.08.016  1
2014 Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, Evan GI, Cesarman E, Verschuren EW, Ojala PM. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle (Georgetown, Tex.). 13: 3670-84. PMID 25483078 DOI: 10.4161/15384101.2014.964118  0.01
2014 Vogel MJ, Xie L, Guan H, Tooze RM, Maier T, Kostezka U, Maier HJ, Holzmann K, Chan FC, Steidl C, Reichel JB, Weitzer CD, Gehringer F, Kick AB, Cesarman E, et al. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma. Blood. 124: 3118-29. PMID 25232062 DOI: 10.1182/Blood-2014-07-590570  1
2014 Mancuso M, Cesarman E, Erickson D. Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessory. Lab On a Chip. 14: 3809-16. PMID 25117534 DOI: 10.1039/C4Lc00517A  1
2014 Cesarman E. How do viruses trick B cells into becoming lymphomas? Current Opinion in Hematology. 21: 358-68. PMID 24886824 DOI: 10.1097/Moh.0000000000000060  0.01
2014 Jiang L, Mancuso M, Lu Z, Akar G, Cesarman E, Erickson D. Solar thermal polymerase chain reaction for smartphone-assisted molecular diagnostics Scientific Reports. 4. PMID 24553130 DOI: 10.1038/Srep04137  1
2014 Cesarman E. Gammaherpesviruses and lymphoproliferative disorders. Annual Review of Pathology. 9: 349-72. PMID 24111911 DOI: 10.1146/Annurev-Pathol-012513-104656  0.01
2013 Wong LY, Brulois K, Toth Z, Inn KS, Lee SH, O'Brien K, Lee H, Gao SJ, Cesarman E, Ensser A, Jung JU. The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1. Journal of Virology. 87: 12069-79. PMID 23986581 DOI: 10.1128/Jvi.01900-13  1
2013 Nayar U, Lu P, Goldstein RL, Vider J, Ballon G, Rodina A, Taldone T, Erdjument-Bromage H, Chomet M, Blasberg R, Melnick A, Cerchietti L, Chiosis G, Wang YL, Cesarman E. Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies. Blood. 122: 2837-47. PMID 23943653 DOI: 10.1182/Blood-2013-01-479972  1
2013 Cesarman E. Pathology of lymphoma in HIV. Current Opinion in Oncology. 25: 487-94. PMID 23942293 DOI: 10.1097/01.Cco.0000432525.70099.A4  0.01
2013 Byun M, Ma CS, Akçay A, Pedergnana V, Palendira U, Myoung J, Avery DT, Liu Y, Abhyankar A, Lorenzo L, Schmidt M, Lim HK, Cassar O, Migaud M, Rozenberg F, ... ... Cesarman E, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. The Journal of Experimental Medicine. 210: 1743-59. PMID 23897980 DOI: 10.1084/Jem.20130592  1
2013 Mancuso M, Jiang L, Cesarman E, Erickson D. Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles. Nanoscale. 5: 1678-86. PMID 23340972 DOI: 10.1039/C3Nr33492A  1
2013 Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 58-64. PMID 23169503 DOI: 10.1200/Jco.2012.42.4648  1
2012 Giulino-Roth L, Wang K, MacDonald TY, Mathew S, Tam Y, Cronin MT, Palmer G, Lucena-Silva N, Pedrosa F, Pedrosa M, Teruya-Feldstein J, Bhagat G, Alobeid B, Leoncini L, Bellan C, ... ... Cesarman E, et al. Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood. 120: 5181-4. PMID 23091298 DOI: 10.1182/Blood-2012-06-437624  1
2012 Cooper N, Stasi R, Cunningham-Rundles S, Cesarman E, McFarland JG, Bussel JB. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia. British Journal of Haematology. 158: 539-47. PMID 22775462 DOI: 10.1111/J.1365-2141.2012.09184.X  0.01
2012 Cesarman E. Viral lymphomas: can antivirals be used to treat cancer? Hematology (Amsterdam, Netherlands). 17: S83-6. PMID 22507788 DOI: 10.1179/102453312X13336169155899  0.01
2012 Krown SE, Roy D, Lee JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. Journal of Acquired Immune Deficiency Syndromes (1999). 59: 447-54. PMID 22067664 DOI: 10.1097/Qai.0B013E31823E7884  1
2012 Nayar U, Lu P, Vider J, Goldstein RL, Ballon G, Cerchietti L, Chiosis G, Wang YL, Cesarman E. Abstract 4829: A purine scaffold Hsp90 inhibitor has antitumor activity in KSHV-associated malignancies by suppressing vFLIP Cancer Research. 72: 4829-4829. DOI: 10.1158/1538-7445.Am2012-4829  1
2011 Mesri EA, Cesarman E. Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. Cell Host & Microbe. 10: 529-31. PMID 22177556 DOI: 10.1016/J.Chom.2011.11.008  1
2011 Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Letters. 305: 163-74. PMID 21493001 DOI: 10.1016/J.Canlet.2011.03.003  0.01
2011 Krown SE, Dittmer DP, Cesarman E. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma. The Journal of Infectious Diseases. 203: 1082-6. PMID 21450998 DOI: 10.1093/Infdis/Jiq177  1
2011 Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. Blood. 117: 4852-4. PMID 21406721 DOI: 10.1182/Blood-2010-10-310995  1
2011 Ballon G, Chen K, Perez R, Tam W, Cesarman E. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. The Journal of Clinical Investigation. 121: 1141-53. PMID 21339646 DOI: 10.1172/Jci44417  1
2011 Ruan J, Martin P, Furman RR, Lee SM, Cheung K, Vose JM, Lacasce A, Morrison J, Elstrom R, Ely S, Chadburn A, Cesarman E, Coleman M, Leonard JP. Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 690-7. PMID 21189393 DOI: 10.1200/Jco.2010.31.1142  1
2011 Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 64-8. PMID 21068672 DOI: 10.1097/Qai.0B013E3181Fc0141  1
2011 Sun SC, Cesarman E. NF-κB as a target for oncogenic viruses. Current Topics in Microbiology and Immunology. 349: 197-244. PMID 20845110 DOI: 10.1007/82_2010_108  1
2010 Mesri EA, Cesarman E, Boshoff C. Kaposi's sarcoma and its associated herpesvirus. Nature Reviews. Cancer. 10: 707-19. PMID 20865011 DOI: 10.1038/Nrc2888  1
2010 Luan SL, Boulanger E, Ye H, Chanudet E, Johnson N, Hamoudi RA, Bacon CM, Liu H, Huang Y, Said J, Chu P, Clemen CS, Cesarman E, Chadburn A, Isaacson PG, et al. Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration. The Journal of Pathology. 222: 166-79. PMID 20690162 DOI: 10.1002/Path.2752  1
2010 de Oliveira DE, Ballon G, Cesarman E. NF-kappaB signaling modulation by EBV and KSHV. Trends in Microbiology. 18: 248-57. PMID 20452220 DOI: 10.1016/J.Tim.2010.04.001  1
2010 Carbone A, Cesarman E, Gloghini A, Drexler HG. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. Aids (London, England). 24: 479-90. PMID 20051807 DOI: 10.1097/Qad.0B013E3283365395  1
2010 Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, ... ... Cesarman E, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 115: 3008-16. PMID 20023215 DOI: 10.1182/Blood-2009-08-231613  1
2009 Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5039-48. PMID 19752343 DOI: 10.1186/1750-9378-4-S2-P14  1
2009 Ma Q, Cavallin LE, Yan B, Zhu S, Duran EM, Wang H, Hale LP, Dong C, Cesarman E, Mesri EA, Goldschmidt-Clermont PJ. Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 106: 8683-8. PMID 19429708 DOI: 10.1073/Pnas.0812688106  1
2009 Di Bartolo DL, Hyjek E, Keller S, Guasparri I, Deng H, Sun R, Chadburn A, Knowles DM, Cesarman E. Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. Journal of Virology. 83: 4308-15. PMID 19224997 DOI: 10.1128/Jvi.02196-08  1
2009 Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gamma-herpesviruses Blood. 113: 1213-1224. PMID 18955561 DOI: 10.1182/Blood-2008-09-180315  1
2008 Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E. Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome. American Journal of Clinical Pathology. 130: 957-62. PMID 19019774 DOI: 10.1309/Ajcp12Hirwsrqlan  1
2008 Horenstein MG, Moontasri NJ, Cesarman E. The pathobiology of Kaposi's sarcoma: advances since the onset of the AIDS epidemic. Journal of Cutaneous Pathology. 35: 40-4. PMID 18976418 DOI: 10.1111/J.1600-0560.2008.01118.X  0.01
2008 Mark T, Jayabalan D, Coleman M, Pearse RN, Wang YL, Lent R, Christos PJ, Lee JW, Agrawal YP, Matthew S, Ely S, Mazumdar M, Cesarman E, Leonard JP, Furman RR, et al. Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma. British Journal of Haematology. 143: 654-60. PMID 18950461 DOI: 10.1111/J.1365-2141.2008.07374.X  1
2008 Guasparri I, Bubman D, Cesarman E. EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood. 111: 3813-20. PMID 18230756 DOI: 10.1182/Blood-2007-03-080309  1
2008 Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH. Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium. Cancer. 112: 1083-8. PMID 18224669 DOI: 10.1002/Cncr.23108  1
2008 Di Bartolo DL, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 111: 4731-40. PMID 18199825 DOI: 10.1182/Blood-2007-09-110544  1
2007 Bubman D, Guasparri I, Cesarman E. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen. Oncogene. 26: 4979-86. PMID 17310999 DOI: 10.1038/Sj.Onc.1210299  1
2007 Engels EA, Mbulaiteye SM, Othieno E, Gomez M, Mathew S, Cesarman E, Knowles DM, Chadburn A. Kaposi sarcoma-associated herpesvirus in non-Hodgkin lymphoma and reactive lymphadenopathy in Uganda. Human Pathology. 38: 308-14. PMID 17097130 DOI: 10.1016/J.Humpath.2006.08.009  1
2007 Chiu A, Xu W, He B, Dillon SR, Gross JA, Sievers E, Qiao X, Santini P, Hyjek E, Lee JW, Cesarman E, Chadburn A, Knowles DM, Cerutti A. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood. 109: 729-39. PMID 16960154 DOI: 10.1182/Blood-2006-04-015958  1
2007 Ambinder RF, Cesarman E. Clinical and pathological aspects of EBV and KSHV infection Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. 885-903. DOI: 10.1017/CBO9780511545313.051  1
2006 Lee JW, Chen Q, Knowles DM, Cesarman E, Wang YL. beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. The Journal of Molecular Diagnostics : Jmd. 8: 385-9. PMID 16825513 DOI: 10.2353/Jmoldx.2006.050150  1
2006 Cesarman E, Mesri EA. Pathogenesis of viral lymphomas. Cancer Treatment and Research. 131: 49-88. PMID 16704166 DOI: 10.1007/978-0-387-29346-2_2  1
2006 Wang YL, Lee JW, Cesarman E, Jin DK, Csernus B. Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts. The Journal of Molecular Diagnostics : Jmd. 8: 231-9. PMID 16645210 DOI: 10.2353/Jmoldx.2006.040404  1
2006 Keller SA, Hernandez-Hopkins D, Vider J, Ponomarev V, Hyjek E, Schattner EJ, Cesarman E. NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood. 107: 3295-302. PMID 16380446 DOI: 10.1182/Blood-2005-07-2730  1
2006 Guasparri I, Wu H, Cesarman E. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling. Embo Reports. 7: 114-9. PMID 16311516 DOI: 10.1038/Sj.Embor.7400580  1
2006 Cannon M, Cesarman E, Boshoff C. KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood. 107: 277-84. PMID 16150942 DOI: 10.1182/Blood-2005-06-2350  1
2005 Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5696-704. PMID 16110029 DOI: 10.1200/Jco.2005.14.803  1
2005 Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 106: 1538-43. PMID 15914552 DOI: 10.1182/Blood-2005-04-1437  1
2005 Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, Cesarman E, Hutt-Fletcher L, Jung JU. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA. Journal of Virology. 79: 4651-63. PMID 15795251 DOI: 10.1128/Jvi.79.8.4651-4663.2005  0.01
2005 Fan W, Bubman D, Chadburn A, Harrington WJ, Cesarman E, Knowles DM. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. Journal of Virology. 79: 1244-51. PMID 15613351 DOI: 10.1128/Jvi.79.2.1244-1251.2005  1
2004 Di Bartolo D, Cesarman E. Uncovering the complexities of Kaposi's sarcoma through genome-wide expression analysis. Genome Biology. 5: 247. PMID 15535873 DOI: 10.1186/Gb-2004-5-11-247  0.01
2004 Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. The American Journal of Surgical Pathology. 28: 1401-16. PMID 15489644 DOI: 10.1097/01.Pas.0000138177.10829.5C  1
2004 Guasparri I, Keller SA, Cesarman E. KSHV vFLIP is essential for the survival of infected lymphoma cells. The Journal of Experimental Medicine. 199: 993-1003. PMID 15067035 DOI: 10.1084/Jem.20031467  1
2003 Cesarman E. Kaposi's sarcoma-associated herpesvirus--the high cost of viral survival. The New England Journal of Medicine. 349: 1107-9. PMID 13679522 DOI: 10.1056/Nejmp038125  0.01
2003 Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematology/Oncology Clinics of North America. 17: 717-45. PMID 12852653 DOI: 10.1016/S0889-8588(03)00044-3  1
2003 Li Z, Pan L, Cesarman E, Knowles DM. Alterations of mRNA splicing in primary effusion lymphomas. Leukemia & Lymphoma. 44: 833-40. PMID 12802923 DOI: 10.1080/1042819031000068043  1
2003 Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. The American Journal of Surgical Pathology. 27: 293-302. PMID 12604885 DOI: 10.1097/00000478-200303000-00002  1
2003 Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, Dalla-Favera R, Carbone A. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood. 101: 4115-21. PMID 12531789 DOI: 10.1182/Blood-2002-10-3090  1
2003 Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. Journal of Virology. 77: 57-67. PMID 12477810 DOI: 10.1128/Jvi.77.1.57-67.2003  1
2002 Costes V, Faumont N, Cesarman E, Rousset T, Meggetto F, Delsol G, Brousset P. Human herpesvirus-8-associated lymphoma of the bowel in human immunodeficiency virus-positive patients without history of primary effusion lymphoma. Human Pathology. 33: 846-9. PMID 12203218 DOI: 10.1053/Hupa.2002.126184  0.01
2002 Ablashi DV, Chatlynne LG, Whitman JE, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clinical Microbiology Reviews. 15: 439-64. PMID 12097251 DOI: 10.1128/Cmr.15.3.439-464.2002  0.01
2002 Curreli F, Cerimele F, Muralidhar S, Rosenthal LJ, Cesarman E, Friedman-Kien AE, Flore O. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. Journal of Virology. 76: 5208-19. PMID 11967335 DOI: 10.1128/Jvi.76.10.5208-5219.2002  1
2002 Menke DM, Chadbum A, Cesarman E, Green E, Berenson J, Said J, Tiemann M, Parwaresch R, Thome SD. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection. American Journal of Clinical Pathology. 117: 268-75. PMID 11863223 DOI: 10.1309/7243-Av50-Kj28-V6J9  1
2002 Cesarman E. Epstein-Barr virus (EBV) and lymphomagenesis. Frontiers in Bioscience : a Journal and Virtual Library. 7: e58-65. PMID 11815280 DOI: 10.2741/A907  0.01
2002 Masood R, Cesarman E, Smith DL, Gill PS, Flore O. Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. The American Journal of Pathology. 160: 23-9. PMID 11786394 DOI: 10.1016/S0002-9440(10)64344-1  1
2002 Cesarman E. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 159: 27-37. PMID 11785841 DOI: 10.1007/978-3-642-56352-2_4  0.01
2001 Bernal A, Pastore RD, Asgary Z, Keller SA, Cesarman E, Liou HC, Schattner EJ. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood. 98: 3050-7. PMID 11698290 DOI: 10.1182/Blood.V98.10.3050  1
2000 Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood. 96: 2537-42. PMID 11001908  1
2000 Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM. Telomerase activity in B-Cell non-Hodgkin lymphoma Cancer. 89: 445-452. PMID 10918178 DOI: 10.1002/1097-0142(20000715)89:2<445::AID-CNCR33>3.0.CO;2-T  1
2000 Cesarman E, Mesri EA, Gershengorn MC. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? Journal of Experimental Medicine. 191: 417-421. PMID 10662787 DOI: 10.1084/Jem.191.3.417  1
2000 Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood. 96: 2537-2542. DOI: 10.1182/Blood.V96.7.2537.H8002537_2537_2542  1
1999 Cannon JS, Nicholas J, Orenstein JM, Mann RB, Murray PG, Browning PJ, DiGiuseppe JA, Cesarman E, Hayward GS, Ambinder RF. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. The Journal of Infectious Diseases. 180: 824-8. PMID 10438372 DOI: 10.1086/314956  1
1998 Cesarman E, Godwin JH. HIV/AIDS case histories: diagnostic problems. Primary effusion lymphoma. Aids Patient Care and Stds. 12: 403-4. PMID 11361976 DOI: 10.1089/APC.1998.12.403  0.01
1998 Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome Blood. 92: 2294-2302. PMID 9746767 DOI: 10.1182/Blood.V92.7.2294.2294_2294_2302  1
1998 Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, Mears JG, Zangwill SD, Addonizio LJ, Michler RE, Knowles DM. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant Cancer. 82: 1978-1987. PMID 9587133 DOI: 10.1002/(Sici)1097-0142(19980515)82:10<1978::Aid-Cncr23>3.0.Co;2-P  1
1997 Horenstein MG, Cesarman E, Wang X, Linkov I, Prieto VG, Louie DC. Cyclin D1 and retinoblastoma protein expression in Kaposi's sarcoma Journal of Cutaneous Pathology. 24: 585-589. PMID 9449484 DOI: 10.1111/J.1600-0560.1997.Tb01088.X  0.01
1997 DePond W, Said JW, Tasaka T, de Vos S, Kahn D, Cesarman E, Knowles DM, Koeffler HP. Kaposi's sarcoma-associated herpesvirus and human herpesvirus 8 (KSHV/HHV8)-associated lymphoma of the bowel. Report of two cases in HIV-positive men with secondary effusion lymphomas. The American Journal of Surgical Pathology. 21: 719-24. PMID 9199651 DOI: 10.1097/00000478-199706000-00013  1
1997 Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 385: 347-50. PMID 9002520 DOI: 10.1038/385347A0  1
1996 Said JW, Tasaka T, Takeuchi S, Asou H, de Vos S, Cesarman E, Knowles DM, Koeffler HP. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood. 88: 3124-8. PMID 8874212 DOI: 10.1182/Blood.V88.8.3124.Bloodjournal8883124  1
1996 Moore PS, Gao SJ, Dominguez G, Cesarman E, Lungu O, Knowles DM, Garber R, Pellett PE, McGeoch DJ, Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi's Sarcoma Journal of Virology. 70: 549-558. PMID 8523568 DOI: 10.1128/Jvi.70.1.549-558.1996  1
1993 Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer. 72: 3078-90. PMID 8221575 DOI: 10.1002/1097-0142(19931115)72:10<3078::AID-CNCR2820721033>3.0.CO;2-F  1
1987 Cesarman E, Dalla-Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma Science. 238: 1272-1275. PMID 3685977 DOI: 10.1126/Science.3685977  1
1987 Dalla-Favera R, Lombardi L, Pelicci PG, Lanfrancone L, Cesarman E, Neri A. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis Annals of the New York Academy of Sciences. 511: 207-218. PMID 2830825 DOI: 10.1111/J.1749-6632.1987.Tb36249.X  1
Show low-probability matches.